HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

China flag China · Delayed Price · Currency is CNY
3.620
+0.010 (0.28%)
Apr 29, 2026, 3:04 PM CST
Market Cap8.07B +34.5%
Revenue (ttm)2.12B -11.5%
Net Income411.58M +71.0%
EPS0.18 +74.4%
Shares Out2.23B
PE Ratio19.59
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,261,531
Average Volume181,964,451
Open3.610
Previous Close3.610
Day's Range3.530 - 3.660
52-Week Range2.400 - 4.080
Beta0.24
RSI49.90
Earnings DateApr 28, 2026

About SHE:002437

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 2,703
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002437
Full Company Profile

Financial Performance

In 2025, SHE:002437's revenue was 2.14 billion, a decrease of -12.51% compared to the previous year's 2.44 billion. Earnings were 376.91 million, an increase of 61.93%.

Financial Statements